OFIX News and Press, Orthofix Medical Inc. From 10/13/22

Orthofix Medical Inc . (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus, today announced the full market release and first implants of Legacy Demineralized Bone Matrix (DBM), a putty for filling voids or gaps in boney defects or traumatic injuries of...

NEW YORK, NY / ACCESSWIRE / October 13, 2022 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: SeaSpine Holdings Corporation (NA...

Orthofix Medical Inc . (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus, today announced that the Virtuos ™ Lyograft has received the 2022 Spine Technology Award from Orthopedics This Week , the most widely read publication in the Orth...

Orthofix Medical ( NASDAQ: OFIX ) reported preliminary Q3 revenue results $114M, which is seen above analysts estimates, amid a merger announcement with SeaSpine ( NASDAQ: SPNE ). The company said the projected Q3 sales of $114M, shows an incre...

SeaSpine ( NASDAQ: SPNE ) reported preliminary Q3 revenue results, which is seen above analysts' estimates, and raised its FY22 outlook amid announcement of a merger with Orthofix Medical ( NASDAQ: OFIX ). As per preliminary data, the company expects Q3 ...

Lewisville, Texas.-based Orthofix Medical ( NASDAQ: OFIX ) and Carlsbad, Calif.-based SeaSpine ( NASDAQ: SPNE ) are merging in an all-stock transaction. Under the agreement, SeaSpine shareholders will receive 0.4163 Orthofix common stock for 1 SeaSpine stock...

Third quarter net sales of $114 million, an increase of 1% on a reported basis and 5% on a constant currency basis over prior year Global Orthopedics net sales growth of 19% on a constant currency basis driven by commercial channel investments Biologics net...

Highly complementary spine and orthopedics portfolios One of the industry’s broadest biologics and regenerative technology offerings Differentiated and synergistic enabling technologies Meaningful cross-selling revenue synergies and cost savings ...

Data includes results from five-year multi-center IDE study in U.S. of the M6-C disc that also demonstrated strong clinical performance, safety and patient benefits Orthofix Medical Inc . (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus, ...

Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus, today announced that President and Chief Executive Officer Jon Serbousek and Chief Financial Officer Doug Rice will be presenting during the upcoming Sidoti Virtual Investor Conferen...